Gilead seems to be in the lead for coronavirus treatment, strategist says

Amid Monday's sell-off, the biotech sector seemed to fare well on prospects of a coronavirus treatment. Jared Holz, health-care equity strategist at Jefferies, joins "Squawk Box" to discuss.
04:44
Tue, Feb 25 20208:43 AM EST